ID   TRIO_RAT                Reviewed;        3100 AA.
AC   F1M0Z1;
DT   18-JAN-2017, integrated into UniProtKB/Swiss-Prot.
DT   18-JAN-2017, sequence version 4.
DT   02-OCT-2024, entry version 94.
DE   RecName: Full=Triple functional domain protein;
DE            EC=2.7.11.1;
DE   AltName: Full=PTPRF-interacting protein;
GN   Name=Trio;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1627; SER-1632; SER-1633;
RP   THR-1824; SER-2283; SER-2459 AND SER-2463, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [3]
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=26721934; DOI=10.1093/hmg/ddv618;
RA   Ba W., Yan Y., Reijnders M.R., Schuurs-Hoeijmakers J.H., Feenstra I.,
RA   Bongers E.M., Bosch D.G., De Leeuw N., Pfundt R., Gilissen C.,
RA   De Vries P.F., Veltman J.A., Hoischen A., Mefford H.C., Eichler E.E.,
RA   Vissers L.E., Nadif Kasri N., De Vries B.B.;
RT   "TRIO loss of function is associated with mild intellectual disability and
RT   affects dendritic branching and synapse function.";
RL   Hum. Mol. Genet. 25:892-902(2016).
RN   [4]
RP   INTERACTION WITH BSN AND PCLO.
RX   PubMed=27907191; DOI=10.1371/journal.pone.0167535;
RA   Terry-Lorenzo R.T., Torres V.I., Wagh D., Galaz J., Swanson S.K.,
RA   Florens L., Washburn M.P., Waites C.L., Gundelfinger E.D., Reimer R.J.,
RA   Garner C.C.;
RT   "Trio, a Rho Family GEF, Interacts with the Presynaptic Active Zone
RT   Proteins Piccolo and Bassoon.";
RL   PLoS ONE 11:E0167535-E0167535(2016).
CC   -!- FUNCTION: Guanine nucleotide exchange factor (GEF) for RHOA and RAC1
CC       GTPases. Involved in coordinating actin remodeling, which is necessary
CC       for cell migration and growth (By similarity). Plays a key role in the
CC       regulation of neurite outgrowth and lamellipodia formation (By
CC       similarity). In developing hippocampal neurons, limits dendrite
CC       formation, without affecting the establishment of axon polarity. Once
CC       dendrites are formed, involved in the control of synaptic function by
CC       regulating the endocytosis of AMPA-selective glutamate receptors
CC       (AMPARs) at CA1 excitatory synapses (PubMed:26721934). May act as a
CC       regulator of adipogenesis (By similarity).
CC       {ECO:0000250|UniProtKB:O75962, ECO:0000250|UniProtKB:Q0KL02,
CC       ECO:0000269|PubMed:26721934}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- SUBUNIT: Interacts with CARMIL1 (By similarity). Interacts with
CC       PTPRF/LAR (By similarity). Interacts with ANKRD26 (By similarity).
CC       Interacts with Bassoon/BSN and Piccolo/PCLO (PubMed:27907191).
CC       Interacts with the cytoplasmic region of the heterodimer formed by NGFR
CC       and SORCS2. ProNGF binding mediates dissociation of TRIO from the
CC       receptor complex (By similarity). {ECO:0000250|UniProtKB:O75962,
CC       ECO:0000269|PubMed:27907191}.
CC   -!- INTERACTION:
CC       F1M0Z1; Q62765: Nlgn1; NbExp=2; IntAct=EBI-26961238, EBI-7281118;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q0KL02}. Cell
CC       projection {ECO:0000250|UniProtKB:Q0KL02}.
CC   -!- DEVELOPMENTAL STAGE: Highly expressed during the early postnatal period
CC       (P1 to P7) in the hippocampus. At P11, levels start to decrease rapidly
CC       until p19 and then more progressively until adulthood (at protein
CC       level). {ECO:0000269|PubMed:26721934}.
CC   -!- DOMAIN: The N-terminal DBL/GEF domain specifically catalyzes nucleotide
CC       exchange for RAC1, leading to the activation of Jun kinase and the
CC       production of membrane ruffles. The second DBL/GEF domain is an
CC       exchange factor for rhoa and induces the formation of stress fibers.
CC       {ECO:0000250|UniProtKB:O75962}.
CC   -!- PTM: Phosphorylated on serine residue(s).
CC       {ECO:0000250|UniProtKB:O75962}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR07008947; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07008948; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_006232152.1; XM_006232090.3.
DR   SMR; F1M0Z1; -.
DR   IntAct; F1M0Z1; 15.
DR   MINT; F1M0Z1; -.
DR   STRING; 10116.ENSRNOP00000016784; -.
DR   iPTMnet; F1M0Z1; -.
DR   PhosphoSitePlus; F1M0Z1; -.
DR   PaxDb; 10116-ENSRNOP00000016784; -.
DR   GeneID; 310192; -.
DR   UCSC; RGD:1308360; rat.
DR   AGR; RGD:1308360; -.
DR   CTD; 7204; -.
DR   RGD; 1308360; Trio.
DR   eggNOG; KOG0032; Eukaryota.
DR   eggNOG; KOG4240; Eukaryota.
DR   HOGENOM; CLU_000373_1_0_1; -.
DR   InParanoid; F1M0Z1; -.
DR   OrthoDB; 2906033at2759; -.
DR   TreeFam; TF318080; -.
DR   Reactome; R-RNO-193648; NRAGE signals death through JNK.
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   Reactome; R-RNO-416482; G alpha (12/13) signalling events.
DR   Reactome; R-RNO-418885; DCC mediated attractive signaling.
DR   Reactome; R-RNO-8980692; RHOA GTPase cycle.
DR   Reactome; R-RNO-9013148; CDC42 GTPase cycle.
DR   Reactome; R-RNO-9013149; RAC1 GTPase cycle.
DR   Reactome; R-RNO-9013404; RAC2 GTPase cycle.
DR   Reactome; R-RNO-9013408; RHOG GTPase cycle.
DR   Reactome; R-RNO-9013409; RHOJ GTPase cycle.
DR   PRO; PR:F1M0Z1; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0042995; C:cell projection; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0019898; C:extrinsic component of membrane; IBA:GO_Central.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0048786; C:presynaptic active zone; ISO:RGD.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IDA:SynGO.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; IPI:RGD.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IBA:GO_Central.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0007411; P:axon guidance; IBA:GO_Central.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; IDA:SynGO.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB.
DR   GO; GO:0099170; P:postsynaptic modulation of chemical synaptic transmission; ISO:RGD.
DR   CDD; cd13240; PH1_Kalirin_Trio_like; 1.
DR   CDD; cd13241; PH2_Kalirin_Trio_p63RhoGEF; 1.
DR   CDD; cd00160; RhoGEF; 2.
DR   CDD; cd00170; SEC14; 1.
DR   CDD; cd11852; SH3_Kalirin_1; 1.
DR   CDD; cd11853; SH3_Kalirin_2; 1.
DR   CDD; cd00176; SPEC; 6.
DR   CDD; cd14113; STKc_Trio_C; 1.
DR   Gene3D; 1.20.58.60; -; 5.
DR   Gene3D; 3.40.525.10; CRAL-TRIO lipid binding domain; 1.
DR   Gene3D; 1.20.900.10; Dbl homology (DH) domain; 2.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 2.
DR   Gene3D; 2.30.30.40; SH3 Domains; 2.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR001251; CRAL-TRIO_dom.
DR   InterPro; IPR036865; CRAL-TRIO_dom_sf.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR047054; Kalirin_TRIO_PH_1.
DR   InterPro; IPR028570; Kalirin_TRIO_SH3_1.
DR   InterPro; IPR047053; Kalirin_TRIO_SH3_2.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR051336; RhoGEF_Guanine_NuclExch_SF.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR018159; Spectrin/alpha-actinin.
DR   InterPro; IPR002017; Spectrin_repeat.
DR   PANTHER; PTHR22826; RHO GUANINE EXCHANGE FACTOR-RELATED; 1.
DR   PANTHER; PTHR22826:SF104; TRIPLE FUNCTIONAL DOMAIN PROTEIN; 1.
DR   Pfam; PF13716; CRAL_TRIO_2; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00621; RhoGEF; 2.
DR   Pfam; PF16609; SH3-RhoG_link; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   Pfam; PF22697; SOS1_NGEF_PH; 2.
DR   Pfam; PF00435; Spectrin; 4.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SMART; SM00233; PH; 2.
DR   SMART; SM00325; RhoGEF; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SMART; SM00516; SEC14; 1.
DR   SMART; SM00326; SH3; 2.
DR   SMART; SM00150; SPEC; 6.
DR   SUPFAM; SSF52087; CRAL/TRIO domain; 1.
DR   SUPFAM; SSF48065; DBL homology domain (DH-domain); 2.
DR   SUPFAM; SSF48726; Immunoglobulin; 1.
DR   SUPFAM; SSF50729; PH domain-like; 2.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   SUPFAM; SSF50044; SH3-domain; 2.
DR   SUPFAM; SSF46966; Spectrin repeat; 6.
DR   PROSITE; PS50191; CRAL_TRIO; 1.
DR   PROSITE; PS50010; DH_2; 2.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 2.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50002; SH3; 2.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell projection; Cytoplasm; Disulfide bond;
KW   Guanine-nucleotide releasing factor; Immunoglobulin domain; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; SH3 domain; Transferase.
FT   CHAIN           1..3100
FT                   /note="Triple functional domain protein"
FT                   /id="PRO_0000438732"
FT   DOMAIN          65..210
FT                   /note="CRAL-TRIO"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00056"
FT   REPEAT          311..418
FT                   /note="Spectrin 1"
FT   REPEAT          538..644
FT                   /note="Spectrin 2"
FT   REPEAT          878..984
FT                   /note="Spectrin 3"
FT   REPEAT          1109..1216
FT                   /note="Spectrin 4"
FT   DOMAIN          1292..1467
FT                   /note="DH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          1479..1591
FT                   /note="PH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          1656..1721
FT                   /note="SH3 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          1970..2146
FT                   /note="DH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          2158..2272
FT                   /note="PH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          2556..2621
FT                   /note="SH3 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          2686..2776
FT                   /note="Ig-like C2-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          2797..3051
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..27
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1601..1651
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1738..1907
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1927..1956
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2288..2557
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2644..2668
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1628..1651
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1738..1759
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1806..1835
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1836..1855
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1878..1907
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1931..1955
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2288..2342
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2355..2390
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2401..2418
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2425..2440
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2485..2513
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2528..2557
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        2916
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         2803..2811
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         2826
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         1627
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1632
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1633
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1824
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2283
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2459
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2463
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2636
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75962"
FT   DISULFID        2707..2760
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
SQ   SEQUENCE   3100 AA;  347860 MW;  CF2D837E3D091509 CRC64;
     MSGSSGGATA PAASSGPAAA ASAAGSGCGG GAGEGAEEAA KDLADIAAFF RSGFRKNDEM
     KAMDVLPILK EKVAYLSGGR DKRGGPILTF PARSNHDRMR QEDLRRLISY LACIPSEEVC
     KRGFTVIVDM RGSKWDSIKP LLKILQESFP CCIHIALIIK PDNFWQKQRT NFGSSKFEFE
     TNMVSLEGLT KVVDPSQLTP EFDGCLEYNH EEWIEIRVAF EDYISNAAHM LSRLEELQDV
     LAKKELPQDL EGARNMIDEH SQLKKKVIKA PIEDLDLEGQ KLLQRIQSSE SFPKKNSGSG
     NADLQNLLPK VSTMLDRLHS TRQHLHQMWH VRKLKLDQCF QLRLFEQDAE KMFDWITHNK
     GLFLNSYTEI GASHPHAMEL QTQHNHFAMN CMNVYVNINR IMSVANRLVE SGHYASQQIK
     QIANQLEQEW KAFAAALDER STLLDMSSIF HQKAEKYMSN VDSWCKACGE VDLPSELQDL
     EDAIHHHQGI YEHITLAYSE VSQDGKSLLD KLQRPLTPGS SDSLTASANY SKAVHHVLDV
     IHEVLHHQRQ LENIWQHRKV RLHQRLQLCV FQQDVQQVLD WIENHGEAFL SKHTGVGKSL
     HRARALQKRH EDFEEVAQNT YTNADKLLEA AEQLAQTGEC DPEEIYQAAH QLEDRIQDFV
     RRVEQRKILL DMSVSFHTHV KELWTWLEEL QKELLDDVYA ESVEAVQDLI KRFGQQQQTT
     LQVTVNVIKE GEDLIQQLRD SAISSNKTPH NSSINHIETV LQQLDEAQSQ MEELFQERKI
     KLELFLQLRI FERDAIDIIS DLESWNDELS QQMNDFDTED LTIAEQRLQH HADKALTMNN
     LTFDVIHQGQ DLLQYVNEVQ ASGVELLCDR DVDMATRVQD LLEFLHEKQQ ELDLAAEQHR
     KHLEQCVQLR HLQAEVKQVL GWIRNGESML NAGLITASSL QEAEQLQREH EQFQHAIEKT
     HQSALQVQQK AEAMLQANHY DMDMIRDCAE KVASHWQQLM LKMEDRLKLV NASVAFYKTS
     EQVCSVLESL EQEYKREEDW CGGADKLGPN SETDHVTPMI SKHLEQKEAF LKACTLARRN
     ADVFLKYLHR NSVSMPGMVT HIKAPEQQVK NILNELFQRE NRVLHYWTMR KRRLDQCQQY
     VVFERSAKQA LEWIHDNGEF YLSTHTSTGS SIQHTQELLK EHEEFQITAK QTKERVKLLI
     QLADGFCEKG HAHAAEIKKC VTAVDKRYRD FSLRMEKYRT SLEKALGISS DSNKSSKSLQ
     LDIIPASIPG SEVKLRDAAH ELNEEKRKSA RRKEFIMAEL IQTEKAYVRD LRECMDTYLW
     EMTSGVEEIP PGIVNKELII FGNMQEIYEF HNNIFLKELE KYEQLPEDVG HCFVTWADKF
     QMYVTYCKNK PDSTQLILEH AGSYFDEIQQ RHGLANSISS YLIKPVQRIT KYQLLLKELL
     TCCEEGKGEI KDGLEVMLSV PKRANDAMHL SMLEGFDENI ESQGELILQE SFQVWDPKTL
     IRKGRERHLF LFEMSLVFSK EVKDSSGRSK YLYKSKLFTS ELGVTEHVEG DPCKFALWVG
     RTPTSDNKIV LKASSIENKQ DWIKHIREVI QERTVHLRGA LKEPIHIPKT APAARQKGRR
     DGEDLDSQGD GSSQPDTISI ASRTSQNTLD SDKLSGGCEL TVVIHDFTAC NSNELTIRRG
     QTVEVLERPH DKPDWCLVRT TDRSPAAEGL VPCGSLCIAH SRSSMEMEGI FNHKDSLSVS
     SNDASPPASV ASLQPHMMGA QSSPGPKRPG NTLRKWLTSP VRRLSSGKAD GHAKKLAHKH
     KKSREVRKSA DAGSQKDSDD SAATPQDETI EERGRNEGLS SGTLSKSSSS GMQSCGEEEG
     EEGADAVPLP PPMAIQQHSL LQPDSQDDKA SSRLLVRPTS SETPSAAELV SAIEELVKSK
     MALEDRPSSL LVDQGDSSSP SFNPSDNSLL SSSSPIDEME ERKCSLSLKR RHYVLQELVE
     TERDYVRDLG CVVEGYMALM KEDGVPDDMK GKDKIVFGNI HQIYDWHRDF FLGELEKCLE
     DPEKLGSLFV KHERRLHMYI VYCQNKPKSE HIVSEYIDTF FEDLKQRLGH RLQLTDLLIK
     PVQRIMKYQL LLKDFLKYSK KASLDTSELE KAVEVMCIVP KRCNDMMNVG RLQGFDGKIV
     AQGKLLLQDT FLVTDQDAGL LPRCKERRVF LFEQIVIFSE PLDKKKGFSM PGFLFKNSIK
     VSCLCLEENV ESDPCKFALT SRTGDAVETF ILHSSSPSVR QTWIHEINQI LENQRNFLNA
     LTSPIEYQRN HSGGGGSGSG GSSGGGGGSG GSGASSGGSS SHGSGPSSCS SGPSSSRSRP
     SRIPQPVRHH PPMLVSSAAS SQAEADKMSG MSAPSPSLPT PSNSLALEAS LGQPSRLPLS
     GDSEGHERET EPIPKMKVME SPRKALGSTS GTSQDGNTKD ARGNLGPLPL GKTRPGAVSP
     LNSPLSTTFP SPFGKEAFPP SSPLQKGGSF WSSIPASPAS RPSSFTFPGD SDSLQRQTHR
     HAAPSKDTDR MSTCSSASEQ SVQSTQSNGS ESSSSSNIST MLVTHEYTAV KEDEINVYQG
     EVVQILASNQ QNMFLVFRAA TDQCPAAEGW IPGFVLGHTS AVIMENPDGT FKKSTSWHTA
     LRLRKKSEKK DKDGKRDGKL ENGYRKPREG LSNKLLNPNY IYDVPPEFVI PLSEVTCETG
     ETVVFRCRVC GRPKASITWK GPEHNTLNND DHYNISYSDV GEATLKIIGV STEDDGVYTC
     IAVNDMGSAS SSASLRVLGP GSDGIVVTWK DNFDAFYSEV AELGRGRFAV VKKCDQKGTK
     RAVATKFVNK KLMKRDQVTH ELGILQNLQH PLFVSLLDTF ETPTSYVLVL ELADQGRLLD
     CVVRWGSLTE GKVRAHLGEV LEAVRYLHNC RIAHLDLKPE NILVDQSLAK PTIKLTDFGD
     AVQLNTTYYI HQLLGNPEFA APEIILGNPV SLTADTWSVG VLTYVLLSGV SPFLDDSVEE
     TCLNICRLDF SFPEDYFQGV SQKAKEFVCF LLQEDPAKRP SAALALQEQW LQAGNGSGKG
     MGVLDTSRLT SFIERRKHQN DVRPIRSIKN FLQSRLLPRV
//
